• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在药物发现与药物递送中的应用:变革个性化医疗

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.

作者信息

Serrano Dolores R, Luciano Francis C, Anaya Brayan J, Ongoren Baris, Kara Aytug, Molina Gracia, Ramirez Bianca I, Sánchez-Guirales Sergio A, Simon Jesus A, Tomietto Greta, Rapti Chrysi, Ruiz Helga K, Rawat Satyavati, Kumar Dinesh, Lalatsa Aikaterini

机构信息

Department of Pharmaceutics and Food Science, School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.

Instituto Universitario de Farmacia Industrial, 28040 Madrid, Spain.

出版信息

Pharmaceutics. 2024 Oct 14;16(10):1328. doi: 10.3390/pharmaceutics16101328.

DOI:10.3390/pharmaceutics16101328
PMID:39458657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11510778/
Abstract

Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advanced computational methods. These innovations have unlocked unprecedented opportunities for the acceleration of drug discovery and delivery, the optimization of treatment regimens, and the improvement of patient outcomes. AI is swiftly transforming the pharmaceutical industry, revolutionizing everything from drug development and discovery to personalized medicine, including target identification and validation, selection of excipients, prediction of the synthetic route, supply chain optimization, monitoring during continuous manufacturing processes, or predictive maintenance, among others. While the integration of AI promises to enhance efficiency, reduce costs, and improve both medicines and patient health, it also raises important questions from a regulatory point of view. In this review article, we will present a comprehensive overview of AI's applications in the pharmaceutical industry, covering areas such as drug discovery, target optimization, personalized medicine, drug safety, and more. By analyzing current research trends and case studies, we aim to shed light on AI's transformative impact on the pharmaceutical industry and its broader implications for healthcare.

摘要

人工智能(AI)涵盖了制药公司已经使用了数十年的广泛技术,包括机器学习、深度学习和其他先进的计算方法。这些创新为加速药物发现和交付、优化治疗方案以及改善患者预后带来了前所未有的机遇。人工智能正在迅速改变制药行业,彻底变革从药物研发到个性化医疗的方方面面,包括靶点识别与验证、辅料选择、合成路线预测、供应链优化、连续生产过程中的监测或预测性维护等等。虽然人工智能的整合有望提高效率、降低成本并改善药物和患者健康,但从监管角度来看,它也引发了重要问题。在这篇综述文章中,我们将全面概述人工智能在制药行业的应用,涵盖药物发现、靶点优化、个性化医疗、药物安全等领域。通过分析当前的研究趋势和案例研究,我们旨在阐明人工智能对制药行业的变革性影响及其对医疗保健的更广泛影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/893b7eb6d1b3/pharmaceutics-16-01328-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/80579e65e25a/pharmaceutics-16-01328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/4b80395f395d/pharmaceutics-16-01328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/1841dc02ba61/pharmaceutics-16-01328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/c05a2f50ed07/pharmaceutics-16-01328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/893b7eb6d1b3/pharmaceutics-16-01328-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/80579e65e25a/pharmaceutics-16-01328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/4b80395f395d/pharmaceutics-16-01328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/1841dc02ba61/pharmaceutics-16-01328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/c05a2f50ed07/pharmaceutics-16-01328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560f/11510778/893b7eb6d1b3/pharmaceutics-16-01328-g005.jpg

相似文献

1
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.人工智能在药物发现与药物递送中的应用:变革个性化医疗
Pharmaceutics. 2024 Oct 14;16(10):1328. doi: 10.3390/pharmaceutics16101328.
2
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery.在药物递送变革的背景下整合人工智能用于药物发现。
Life (Basel). 2024 Feb 7;14(2):233. doi: 10.3390/life14020233.
3
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery.变革药物化学:人工智能在早期药物发现中的应用。
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1259. doi: 10.3390/ph16091259.
4
Revolutionizing the food industry: The transformative power of artificial intelligence-a review.变革食品行业:人工智能的变革力量——综述
Food Chem X. 2024 Oct 1;24:101867. doi: 10.1016/j.fochx.2024.101867. eCollection 2024 Dec 30.
5
Advances in artificial intelligence for drug delivery and development: A comprehensive review.人工智能在药物输送和开发中的进展:全面综述。
Comput Biol Med. 2024 Aug;178:108702. doi: 10.1016/j.compbiomed.2024.108702. Epub 2024 Jun 7.
6
Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.药理学研究中的人工智能与机器学习:弥合数据与药物发现之间的差距
Cureus. 2023 Aug 30;15(8):e44359. doi: 10.7759/cureus.44359. eCollection 2023 Aug.
7
Artificial Intelligence, the Digital Surgeon: Unravelling Its Emerging Footprint in Healthcare - The Narrative Review.人工智能,数字外科医生:揭示其在医疗保健领域的新兴足迹——叙述性综述
J Multidiscip Healthc. 2024 Aug 15;17:4011-4022. doi: 10.2147/JMDH.S482757. eCollection 2024.
8
Reimagining Healthcare: Unleashing the Power of Artificial Intelligence in Medicine.重塑医疗保健:释放人工智能在医学中的力量。
Cureus. 2023 Sep 4;15(9):e44658. doi: 10.7759/cureus.44658. eCollection 2023 Sep.
9
Leveraging Artificial Intelligence and Machine Learning in Regenerative Orthopedics: A Paradigm Shift in Patient Care.在再生骨科中利用人工智能和机器学习:患者护理的范式转变。
Cureus. 2023 Nov 30;15(11):e49756. doi: 10.7759/cureus.49756. eCollection 2023 Nov.
10
A Comprehensive Investigation: Developing the Pharmaceutical Industry through Artificial Intelligence.一项全面调查:通过人工智能发展制药行业
Curr Drug Discov Technol. 2024 Sep 5. doi: 10.2174/0115701638313233240830132804.

引用本文的文献

1
Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions.代谢、炎症和肿瘤疾病中的核受体:作用机制、治疗进展及未来方向
Eur J Med Res. 2025 Sep 9;30(1):843. doi: 10.1186/s40001-025-03073-6.
2
Clinical trials of nanoparticle-enhanced CAR-T and NK cell therapies in oncology: overcoming translational and clinical challenges - a mini review.纳米颗粒增强型CAR-T和NK细胞疗法在肿瘤学中的临床试验:克服转化和临床挑战——一篇综述
Front Med (Lausanne). 2025 Aug 6;12:1655693. doi: 10.3389/fmed.2025.1655693. eCollection 2025.
3
The future of pharmaceuticals: Artificial intelligence in drug discovery and development.

本文引用的文献

1
Insights and Considerations in Development and Performance Evaluation of Generative Adversarial Networks (GANs): What Radiologists Need to Know.生成对抗网络(GANs)开发与性能评估中的见解与思考:放射科医生需要了解的内容。
Diagnostics (Basel). 2024 Aug 13;14(16):1756. doi: 10.3390/diagnostics14161756.
2
Impact of Artificial Intelligence on Drug Development and Delivery.人工智能对药物研发与递送的影响。
Curr Top Med Chem. 2024 Aug 12. doi: 10.2174/0115680266324522240725053634.
3
AI for drug discovery.用于药物发现的人工智能。
制药的未来:药物研发中的人工智能
J Pharm Anal. 2025 Aug;15(8):101248. doi: 10.1016/j.jpha.2025.101248. Epub 2025 Feb 26.
4
Advanced drug delivery systems for oral squamous cell carcinoma: a comprehensive review of nanotechnology-based and other innovative approaches.口腔鳞状细胞癌的先进药物递送系统:基于纳米技术及其他创新方法的综合综述
Front Drug Deliv. 2025 Jun 27;5:1596964. doi: 10.3389/fddev.2025.1596964. eCollection 2025.
5
Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications.纳米植物医学:利用纳米载体中植物源植物化学物质用于靶向人类健康应用。
Molecules. 2025 Jul 29;30(15):3177. doi: 10.3390/molecules30153177.
6
Integrating CT radiomics and clinical data with machine learning to predict fibrosis progression in coalworker pneumoconiosis.将CT影像组学和临床数据与机器学习相结合以预测煤工尘肺纤维化进展
Front Med (Lausanne). 2025 Jul 22;12:1599739. doi: 10.3389/fmed.2025.1599739. eCollection 2025.
7
Bridging technology and medicine: artificial intelligence in targeted anticancer drug delivery.连接技术与医学:人工智能在靶向抗癌药物递送中的应用
RSC Adv. 2025 Aug 4;15(34):27795-27815. doi: 10.1039/d5ra03747f. eCollection 2025 Aug 1.
8
Development of Co-Amorphous Systems for Inhalation Therapy-Part 1: From Model Prediction to Clinical Success.用于吸入治疗的共无定形系统的开发——第1部分:从模型预测到临床成功
Pharmaceutics. 2025 Jul 16;17(7):922. doi: 10.3390/pharmaceutics17070922.
9
From Molecules to Medicines: The Role of AI-Driven Drug Discovery Against Alzheimer's Disease and Other Neurological Disorders.从分子到药物:人工智能驱动的药物发现对阿尔茨海默病及其他神经疾病的作用。
Pharmaceuticals (Basel). 2025 Jul 14;18(7):1041. doi: 10.3390/ph18071041.
10
From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes.从实验室到临床:人工智能如何重塑药物研发时间表和行业成果。
Pharmaceuticals (Basel). 2025 Jun 30;18(7):981. doi: 10.3390/ph18070981.
Nat Rev Urol. 2024 Sep;21(9):517. doi: 10.1038/s41585-024-00931-6.
4
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases.基于人工智能的临床试验入组标准和终点评估自动化在肝脏疾病中的应用。
Nat Med. 2024 Oct;30(10):2914-2923. doi: 10.1038/s41591-024-03172-7. Epub 2024 Aug 7.
5
Mobile applications on app stores for deprescribing: A scoping review.应用商店中用于减药的移动应用程序:一项范围综述。
Br J Clin Pharmacol. 2025 Jan;91(1):55-65. doi: 10.1111/bcp.16191. Epub 2024 Aug 4.
6
Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability.利用 3D 打印微流控微混合器连续制备载有 melatonin 的 SNEDDS,提高抗氧化活性和皮肤渗透性。
Int J Pharm. 2024 Sep 30;663:124536. doi: 10.1016/j.ijpharm.2024.124536. Epub 2024 Jul 27.
7
The Introduction of AI Into Decentralized Clinical Trials: Preparing for a Paradigm Shift.人工智能引入去中心化临床试验:为范式转变做准备。
JACC Adv. 2024 Jul 5;3(8):101094. doi: 10.1016/j.jacadv.2024.101094. eCollection 2024 Aug.
8
Increasing acceptance of AI-generated digital twins through clinical trial applications.通过临床试验应用,提高对人工智能生成的数字孪生体的接受度。
Clin Transl Sci. 2024 Jul;17(7):e13897. doi: 10.1111/cts.13897.
9
AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin.基于人工智能的用于抑制硬化蛋白的FDA批准的重新利用药物的3D-QSAR模型。
Technol Health Care. 2024;32(5):3007-3019. doi: 10.3233/THC-231358.
10
AI-Powered Microfluidics: Shaping the Future of Phenotypic Drug Discovery.人工智能驱动的微流控技术:塑造表型药物发现的未来。
ACS Appl Mater Interfaces. 2024 Jul 31;16(30):38832-38851. doi: 10.1021/acsami.4c07665. Epub 2024 Jul 17.